IA
IPXL

Icon Advisers’s Impax Laboratories, Inc. IPXL Stock Holding History

Icon Advisers’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-16,255
Closed -$330K – 426
2017
Q3 		$330K Sell
16,255
-8,545
-34% -$163K 0.02% 351
2017
Q2 		$399K Sell
24,800
-106,900
-81% -$1.58M 0.03% 357
2017
Q1 		$1.67M Buy
131,700
+110,600
+524% +$1.34M 0.11% 219
2016
Q4 		$280K Hold
21,100
– – 0.02% 389
2016
Q3 		$500K Buy
+21,100
New +$567K 0.03% 362

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Icon Advisers's IPXL Position: Q4 2017 in Review

Icon Advisers sold out of Impax Laboratories, Inc. (IPXL) in Q4 2017, closing a stake of 16,255 shares — an estimated $330K sold.

Icon Advisers first reported a position in IPXL in Q3 2016 and held it in 5 quarters. The position peaked at $1.67M in Q1 2017. 200 funds tracked by Wall St. Rank hold IPXL as of Q4 2017.

  • Icon Advisers reported no remaining Impax Laboratories, Inc. position as of Q4 2017 after selling out during the quarter.
  • Icon Advisers sold 16,255 Impax Laboratories, Inc. shares in Q4 2017, an estimated $330K.
  • Icon Advisers first reported a position in Impax Laboratories, Inc. in Q3 2016 and held it in 5 quarters.
  • Icon Advisers's Impax Laboratories, Inc. position peaked at $1.67M in Q1 2017.
  • 200 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2017.

Based on Icon Advisers's 13F filing for Q4 2017, filed 6 Feb 2018.